Dr. Upadhyaya on Risk Factors for Pediatric Ependymoma

Video

Santhosh Upadhyaya, MD, neuro-oncologist, St. Jude Children’s Research Hospital, discusses risk factors for developing pediatric ependymoma.

Santhosh Upadhyaya, MD, neuro-oncologist, St. Jude Children’s Research Hospital, discusses risk factors for developing pediatric ependymoma.

Most pediatric patients who are diagnosed with ependymoma are diagnosed without any known predisposition to the cancer other than neurofibromatosis, says Upadhyaya. Researchers have been unable to identify potential risk factors that lead to the development of the malignancy.

However, research regarding risk factors for relapse suggests that patients who have most of their tumor removed in surgery prior to receiving radiation have the best chance of cure. This is difficult to achieve, explains Upadhyaya, as these tumors are located in difficult-to-reach areas of the brain. Any aggressive attempt at resection may lead to neurological problems that may be permanent, Upadhyaya says. Using chemotherapy as a bridge in these situations may enable a patient’s tumor to shrink during the recovery process, potentially enabling them to undergo a second procedure.

Related Videos
Christian Marth, MD, PhD, head, professor, Department of Obstetrics and Gynecology, Innsbruck Medical University
Mansoor Raza Mirza, MD, chief oncologist, Department of Oncology, Rigshospitalet, Copenhagen University Hospital
Judy Hayek, MD, gynecologic oncology fellow, State University of New York (SUNY) Downstate College of Medicine
Leslie M. Randall, MD, MAS, professor, division head, Department of Obstetrics and Gynecology – Gynecologic Oncology, Virginia Commonwealth University School of Medicine Obstetrics and Gynecology
Dimitrios Nasioudis, MD, fellow, Gynecologic Oncology, Perelman School of Medicine, the University of Pennsylvania
Sara Corvigno, MD, PhD, translational researcher, oncology, The University of Texas MD Anderson Cancer Center
I-Chia (Daniel) Liu, MD
Robert W. Mutter, MD
Saad J. Kenderian, MB, CHB, consultant, Division of Hematology, Department of Internal Medicine, Department of Immunology, Department of Molecular Medicine, assistant professor, oncology, immunology, medicine, Mayo Clinic
Mary-Ellen Taplin, MD